Showing 1 - 14 results of 14 for search '"Lu (state)"', query time: 0.33s Refine Results
  1. 1
  2. 2

    The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals by Men Y, Wang XX, Li RJ, Zhang Y, Tian W, Yao HJ, Ju RJ, Ying X, Zhou J, Li N, Zhang L, Yu Y, Lu WL

    Published 2011-12-01
    “…Ying Men*, Xiao-Xing Wang*, Ruo-Jing Li, Yan Zhang, Wei Tian, Hong-Juan Yao, Rui-Jun Ju, Xue Ying, Jia Zhou, Nan Li, Liang Zhang, Yang Yu, Wan-Liang LuState Key Laboratory of Natural and Biomimetic Drugs, and School of Pharmaceutical Sciences, Peking University, Beijing, People's Republic of China*These authors contributed equally to this manuscriptBackground: Multidrug resistance (MDR) of cancers can be circumvented by inducing programmed cell death, which is known as apoptosis. …”
    Get full text
    Article
  3. 3

    Transition steps in peroxide reduction and a molecular switch for peroxide robustness of prokaryotic peroxiredoxins by Kamariah, Neelagandan, Sek, Mun Foong, Eisenhaber, Birgit, Eisenhaber, Frank, Grüber, Gerhard

    Published 2018
    “…Complementary to mutational and enzymatic results, these data unravel the essential role of the C-terminal tail of bacterial Prxs to act as a molecular switch, mediating the transition from an FF to a LU state. In addition, we propose that the C-terminal tail has influence on the propensity of the disulphide bond formation, indicating that as a consequence on the robustness and sensitivity to over-oxidation. …”
    Get full text
    Get full text
    Journal Article
  4. 4
  5. 5

    Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene by Yan Y, Li XQ, Duan JL, Bao CJ, Cui YN, Su ZB, Xu JR, Luo Q, Chen M, Xie Y, Lu WL

    Published 2019-05-01
    “…Yan Yan, Xue-Qi Li, Jia-Lun Duan, Chun-Jie Bao, Yi-Nuo Cui, Zhan-Bo Su, Jia-Rui Xu, Qian Luo, Ming Chen, Ying Xie, Wan-Liang LuState Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, and School of Pharmaceutical Sciences, Peking University, Beijing, People’s Republic of ChinaBackground: Neo-adjuvant chemotherapy is an effective strategy for improving treatment of breast cancers. …”
    Get full text
    Article
  6. 6

    TRPM8 genetic variations associated with COPD risk in the Chinese Han population by Xiong M, Wang J, Guo M, Zhou Q, Lu W

    Published 2016-10-01
    “…Mingmei Xiong,* Jian Wang,* Meihua Guo, Qipeng Zhou, Wenju Lu State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, People’s Republic of China *These authors contributed equally to this work Abstract: TRPM8 plays a key role in COPD. …”
    Get full text
    Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14